Gardasil is a vaccine, licensed for use in June 2006, by the FDA. It targets four strains of human papillomavirus (HPV) -- HPV-6, 11, 16, and 18. HPV-16 and HPV-18 account for about 70% of all ...
New research has found the HPV vaccine can reduce cases of cervical cancer by nearly 90%. Cervical cancer is the fourth most common cancer in women around the world, killing more than 300,000 each ...
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback